Fingerprint
Dive into the research topics of 'Ranibizumab versus verteporfin for neovascular age-related macular degeneration'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Ranibizumab versus verteporfin for neovascular age-related macular degeneration
David M. Brown, Peter K. Kaiser, Mark Michels, Gisele Soubrane, Jeffrey S. Heier, Robert Y. Kim, Judy P. Sy, Susan Schneider
Research output: Contribution to journal › Article › peer-review
2968
Scopus
citations